跳至主要内容

Correlation of Endoscopic Findings with Various Helicobacter pylori Tests among Dyspeptic Patients

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50373#.VDs19lfHRK0

Author(s)  
Background: Helicobacter pylori is the most common chronic bacterial infection, and a significant etiological factor in acid peptic diseases and gastric cancer. Dyspepsia is a common gastrointestinal disorder, and the most common indication for gastroscopy. Detection of H. pylori during endoscopy has become standard clinical practice. Elevated levels of inflammatory markers such as C-reactive protein (CRP), are associated with pathological changes, and hence give useful information for exact diagnosis and therapy. Objectives: To determine the relationship between endoscopic findings, highly sensitive C-reactive protein level (hs-CRP) and H. pylori infection among dyspeptic patients using serological tests, stool antigen for H. pylori and antral histology. Methods: This was a prospective study; patients with dyspepsia, who referred to Kurdistan Teaching Center of Gastroenterology & Hepatology in Sulaimani City were assessed, during the period of December 2012 to March 2014. They underwent gastroscopy, and biopsies were taken from the corpus and antral portions of antral portion for histopathological exam. Patients’ serum samples were tested for H. pylori infection using ELISA method to detect (IgG & IgA) anti-bodies and stool samples were examined using rapid immunoassay method to detect H. pylori antigens. hs-CRP was assessed using ELISA. Results: One hundred dyspeptic patients were included in the study. The mean age was 34.2 years and male comprised 54% of the study samples. The common findings in oesophagogastroduodenoscopy (OGD) examination were antral gastropathy (59%) and duodenal ulcer (21%). A statistically significant (P < 0.01) correlation was found between hs-CRP and H. pylori IgG and IgA levels (titer). There was a highly significant (P < 0.01) correlation between the level of H. pylori IgG and the endoscopic findings. The highest serum level of H. pylori IgG was found in duodenal ulcer and antral gastritis, (88.86 ± 42.0) and (70.05 ± 35.2) Au/ml, respectively. There was a highly significant correlation (P < 0.01) between endoscopic findings and H. pylori positive antral biopsy, in duodenal ulcer, antral gastritis and duodenitis was 100%, 94.9% and 75% respectively. Also duodenal ulcer and antral gastritis showed high mean and percentage but no significant differences in both H. pylori IgA and stool Antigen.
Cite this paper
Mohammed, M. (2014) Correlation of Endoscopic Findings with Various Helicobacter pylori Tests among Dyspeptic Patients. International Journal of Clinical Medicine, 5, 1180-1188. doi: 10.4236/ijcm.2014.519151. 
 

[1] Sobieraj, D.M., Coleman, S.M. and Coleman, C.I. (2011) US Prevalence of Upper Gastrointestinal Symptoms: A Systematic Literature Review. American Journal of Managed Care, 17, 449-458.
[2] Roussos, A., Philippou, N. and Gourgoulianis, K.I. (2003) Helicobacter pylori Infection and Respiratory Diseases: A Review. World Journal of Gastroenterology, 9, 5-8.
[3] Jia, E.Z., Zhao, F.J., Hao, B., Zhu, T.B., Wang, L.S., Chen, B., et al. (2009) Helicobacter pylori Infection Is Associated with Decreased Serum Levels of High Density Lipoprotein, but Not with the Severity of Coronary Atherosclerosis. Lipids in Health and Disease, 23, 59.
http://dx.doi.org/10.1186/1476-511X-8-59
[4] Atherton, J. (2006) The Pathogenesis of H. pylori Induced Gastro-Duodenal Diseases. Annual Review of Pathology: Mechanisms of Disease, 1, 63-96.
http://dx.doi.org/10.1146/annurev.pathol.1.110304.100125
[5] Stenström, B., Mendis, A. and Marshall, B. (2008) Helicobacter pylori—The Latest in Diagnosis and Treatment. Australian Family Physician, 37, 608-612.
[6] Kusters, J.G., van Vliet, A.H. and Kuipers, E.J. (2006) Pathogenesis of Helicobacter pylori Infection. Clinical Microbiology Reviews, 19, 449-490.
http://dx.doi.org/10.1128/CMR.00054-05
[7] Ho, B. and Marshall, B.J. (2000) Accurate Diagnosis of Helicobacter pylori. Serologic Testing. North American Journal of Clinical, 29, 853-862.
[8] Brown, L.M. (2000) Helicobacter pylori: Epidemiology and Routes of Transmission. Epidemiologic Reviews, 22, 283-297.
http://dx.doi.org/10.1093/oxfordjournals.epirev.a018040
[9] Murray, P.R., Rosental, K.S. and Pfllar, M.A. (2005) Medical Microbiology. 5th Edition.
[10] Debabrata, M., James, B. and John, A. (2007) Helicobacter pylori Infection and Peptic Ulcers. Journal of Medicine, 35, 204-209.
http://dx.doi.org/10.1016/j.mpmed.2007.01.006
[11] Cirak, M.Y., Akyön, Y. and Mégraud, F. (2007) Diagnosis of Helicobacter pylori. Helicobacter, 12, 4-9.
http://dx.doi.org/10.1111/j.1523-5378.2007.00542.x
[12] Libby, P. and Ridker, P.M. (2004) Inflammation and Atherosclerosis: Role of C-Reactive Protein in Risk Assessment. The American Journal of Medicine, 116, 9-16.
http://dx.doi.org/10.1016/j.amjmed.2004.02.006
[13] Blake, G.J. and Ridker, P.M. (2003) C-Reactive Protein: A Surrogate Risk Marker or Mediator of Atherothrombosis? American Journal of Physiology, 285, R1250-R1252.
[14] Wilson, A.M., Ryan, M.C. and Boyle, A.J. (2006) The Novel Role of C-Reactive Protein in Cardiovascular Disease: Risk Marker or Pathogen. International Journal of Cardiology, 106, 291-297.
http://dx.doi.org/10.1016/j.ijcard.2005.01.068
[15] Grdanoska, T., Zafirovska, P., Jaglikovski, B., Pavlovska, I., Zafirova, B., Tosheska-Trajkovska, K., et al. (2012) Chlamydia pneumoniae and Helicobacter pylori Serology: Importance in Patients with Coronary Heart Disease. Materia Socio Medica, 24, 151-156.
http://dx.doi.org/10.5455/msm.2012.24.151-156
[16] Al-Balushi, M.S., Al-Busaidi, J.Z., Al-Daihani, M.S., Shafeeq, M.O. and Hasson, S.S. (2013) Sero-Prevalence of Helicobacter pylori Infection among Asymptomatic Healthy Omani Blood Donors. Asian Pacific Journal of Tropical Disease, 3, 146-149.
http://dx.doi.org/10.1016/S2222-1808(13)60059-6
[17] Price, A.B. (1999) Classification of Gastritis—Yesterday, Today and Tomorrow. Verhandlungen der Deutschen Gesellschaft für Pathologie, 83, 52-55.
[18] Blecker, U., Lanciers, S. and Mahta, D. (1994) Familial Cluster of Helicobacter pylori Infection. Clinical Pediatrics, 13, 307-308.
[19] Baban, F.A. and Mohamma, M.O. (2003) The Prevalence of Helicobacter pylori in Upper Gastro Intestinal Disorders. Journal of Zankoy Sulaimani, Part A, 6, l-8.
[20] Valliani, A., Khan, F., Chagani, B., Khuwaja, A.K., Majid, S., Hashmi, S., et al. (2013) Factors Associated with Helicobacter pylori Infection, Results from a Developing Country-Pakistan. Asian Pacific Journal of Cancer Prevention, 14, 53-56.
http://dx.doi.org/10.7314/APJCP.2013.14.1.53
[21] Abdallah, T.M., Mohammed, H.B., Mohammed, M.H. and Ali, A.A. (2014) Sero-Prevalence and Factors Associated with Helicobacter pylori Infection in Eastern Sudan. Asian Pacific Journal of Tropical Disease, 4, 115-119.
[22] Agbakwuru, E.A., Fatusi, A.O., Ndububa, D.A., Alatise, O.I., Arigbabu, O.A. and Akinola, D.O. (2006) Pattern and Validity of Clinical Diagnosis of Upper Gastrointestinal Diseases in South-West Nigeria. African Health Sciences, 6, 98-103.
[23] Onyekwere, C.A., Hameed, H., Anomneze, E.E. and Chibututu, C. (2008) Upper Gastrointestinal Endoscopy Findings in Nigerians: A Review of 170 Cases in Lagos. The Nigerian Postgraduate Medical Journal, 15, 126-129.
[24] Jeje, E., Olajide, T. and Akande, B. (2013) Upper Gastrointestinal Endoscopy: Our Findings, Our Experience in Lagoon Hospital, Lagos, Nigeria. Macedonian Journal of Medical Sciences, 6, 168-173.
[25] Nkrumah, K.N. (2002) Endoscopic Evaluation of Upper Abdominal Symptoms in Adult Patients, Saudi Aramco-Ai Hasa Health Center, Saudi Arabia. West African Journal of Medicine, 21, 1-4.
[26] Walker, T.D., Karemera, M., Ngabonziza, F. and Kyamanywa, P. (2014) Helicobacter pylori Status and Associated Gastroscopic Diagnoses in a Tertiary Hospital Endoscopy Population in Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108, 305-307.
http://dx.doi.org/10.1093/trstmh/tru029
[27] Lule, G.N., Sang, F. and Ogutu, E.O. (1991) Helicobacter pylori in Peptic Ulcer Disease in Kenya. East African Medical Journal, 68, 324-327.
[28] Kidd, M., Louw, J.A. and Marks, I.N. (1999) Helicobacter pylori in Africa: Observations on an “Enigma within an Enigma”. Journal of Gastroenterology and Hepatology, 14, 851-858.
http://dx.doi.org/10.1046/j.1440-1746.1999.01975.x
[29] Watari, J., Chen, N., Amenta, P.S., Fukui, H., Oshima, T., Tomita, T., et al. (2014) Helicobacter pylori Associated Chronic Gastritis, Clinical Syndromes, Precancerous Lesions, and Pathogenesis of Gastric Cancer Development. World Journal of Gastroenterology, 20, 5461-5473.
http://dx.doi.org/10.3748/wjg.v20.i18.5461
[30] Jafarzadeh, A., Hassanshahi, G.H. and Nemati, M. (2009) Serum Levels of High-Sensitivity C-Reactive Protein (hs-CRP) in Helicobacter pylori-Infected Peptic Ulcer Patients and Its Association with Bacterial CagA Virulence Factor. Digestive Diseases and Sciences, 54, 2612-2616.
http://dx.doi.org/10.1007/s10620-008-0686-z
[31] Stettin, D., Waldmann, A., Ströhl, A. and Hahn, A. (2008) Association between Helicobacter pylori-Infection, C-Reactive Protein and Status of B Vitamins. Advances in Medical Sciences, 53, 205-213.
[32] Kebapcilar, L., Bilgir, O., Cetinkaya, E., Akyol, M., Bilgir, F. and Bozkaya, G. (2010) The Effect of Helicobacter pylori Eradication on Macrophage Migration Inhibitory Factor, C-Reactive Protein and Fetuin-A Levels. Clinics, 65, 799-802.
http://dx.doi.org/10.1590/S1807-59322010000800010
[33] Yoshiko, I., Koji, S., Kentaro, T., Toshimitsu, N., Shozo, K. and Hisao, A. (2008) Significant Association between Helicobacter pylori Infection and Serum C-Reactive Protein. Journal of Medical Sciences, 5, 224-229.
[34] Kanbay, M., Gür, G., Arslan, H., Yilmaz, U. and Boyaciogllu, S. (2005) Does Eradication of Helicobacter pylori Infection Help Normalize Serum Lipid and CRP Levels? Digestive Diseases and Sciences, 50, 1228-1231.
http://dx.doi.org/10.1007/s10620-005-2764-9
[35] Guarner, J., Kalach, N., Elitsur, Y. and Koletzko, S. (2010) Helicobacter pylori Diagnostic Tests in Children: Review of the Literature from 1999 to 2009. European Journal of Pediatrics, 169, 15-25.
http://dx.doi.org/10.1007/s00431-009-1033-x
[36] Bhat, N., Gaensbauer, J., Peek, R.M., Bloch, K., Tham, K.T., Blaser, M.J., et al. (2005) Local and Systemic Immune and Inflammatory Responses to Helicobacter pylori Strains. Clinical and Diagnostic Laboratory Immunology, 12, 1393-1400.
[37] Lenzi, C., Palazzuoli, A., Giordano, N., Alegente, G., Gonnelli, C., Campagna, M.S., et al. (2006) H pylori Infection and Systemic Antibodies to CagA and Heat Shock Protein 60 in Patients with Coronary Heart Disease. World Journal of Gastroenterology, 12, 7815-7820.
[38] Dixon, M.F., Genta, R.M., Yardley, J.H. and Correa, P. (1996) Classification and Grading of Gastritis: The Updated Sydney System. American Journal of Surgical Pathology, 20, 1161-1181.
http://dx.doi.org/10.1097/00000478-199610000-00001
[39] Dixon, M. (2001) Pathology of Gastritis and Peptic Ulceration. In: Mobley, H.L.T., Mendz, G.L. and Hazell, S.L., Eds., Helicobacter pylori: Physiology and Genetics, ASM Press, Washington DC, 459-469.
[40] Yamada, T., Alpers, D.H., Kalloo, A.N., Kaplowitz, N., Owyang, C. and Powell, D.W. (2009) Textbook of Gastroenterology. 5th Edition, Blackwell Publishing, Oxford, 925.
[41] Pérez-Pérez, G.I., Sack, R.B., Reid, R., Santosham, M., Croll, J. and Blaser, M.J. (2003) Transient and Persistent Helicobacter pylori Colonization in Native American Children. Journal of Clinical Microbiology, 41, 2401-2407.
http://dx.doi.org/10.1128/JCM.41.6.2401-2407.2003
[42] Koletzko, S. (2005) Noninvasive Diagnostic Tests for Helicobacter pylori Infection in Children. Canadian Journal of Gastroenterology, 19, 433-439.
[43] Pourakbari, B., Mirsalehian, A., Maleknejad, P., Mamishi, S., Azhdarkosh, H., Daryani, N.E., et al. (2011) Evaluation of a New Antigen for Diagnosis of Helicobacter pylori Infection in Stool of Adult and Children. Helicobacter, 16, 42-46.
http://dx.doi.org/10.1111/j.1523-5378.2010.00813.x
[44] Leal, Y.A., Flores, L.L., García-Cortés, L.B., Cedillo-Rivera, R. and Torres, J. (2008) Antibody-Based Detection Tests for the Diagnosis of Helicobacter pylori Infection in Children: A Meta-Analysis. PLoS ONE, 3, e3751.
http://dx.doi.org/10.1371/journal.pone.0003751
[45] Forné, M., Domínguez, J., Fernández-Bañares, F., Lite, J., Esteve, M., Galí, N., et al. (2000) Accuracy of an Enzyme Immunoassay for the Detection of Helicobacter pylori in Stool Specimens in the Diagnosis of Infection and Post Treatment Check-Up. The American Journal of Gastroenterology, 95, 2200-2205.
http://dx.doi.org/10.1111/j.1572-0241.2000.02303.x
[46] Kabir, S. (2001) Detection of Helicobacter pylori in Faeces by Culture, PCR and Enzyme Immunoassay. Journal of Medical Microbiology, 50, 1021-1029.
[47] Babak, P., Mona, G., Shima, M., Setareh, M., Hossein, A. and Mehri, N. (2013) Diagnosis of Helicobacter pylori Infection by Invasive and Noninvasive Tests. Brazilian Journal of Microbiology, 44, 795-798.
http://dx.doi.org/10.1590/S1517-83822013005000052          eww141013lx
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文